Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download

Pages

25 / 46
Date Title Description PDF
18 Aug 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 11 August and 17 August 2023 Download
11 Aug 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 3 August and 10 August 2023 Download
03 Aug 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 26 July 2023 and 2 August 2023 Download
28 Jul 2023 On business and financial situation ROVI informs on the evaluation process to obtain marketing authorisation for Risvan® Download
05 Jul 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2023 Download

Pages

65 / 158
Date Title Description PDF
03 Jul 2012 Información sobre dividendos Download
13 Jun 2012 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download
26 Apr 2012 Información sobre resultados (2) Download
26 Apr 2012 Información sobre resultados Download
26 Apr 2012 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download

Pages

180 / 194